Much attention has recently been given, at both a state as well as a national level, the challenges associated with the rising costs of insulin. Indeed, staff from the American Diabetes Association recently provided congressional testimony on this topic, noting it an unacceptable situation. When discussed, information is often provided in the form of groups of individuals or national data. NPR recently broke this trend by highlighting this evolving tragety in a very personalized way. See here.